Atul Q2 FY27 Results: Consolidated Net Profit ₹159 Crore on Total Income of ₹1,925 Crore
Earnings
specialty chemicals
Blacklitt Research3 min read
Atul (ATUL) said in a filing on 23 Oct 2026 that consolidated total income for the quarter ended 30 Sep 2026 was ₹1,925.44 crore and consolidated net profit was ₹158.71 crore. Standalone total income was ₹1,673.38 crore and standalone net profit was ₹141.44 crore.
Key highlights
Consolidated
Including its subsidiaries
Total income: ₹1,925.44 crore, up 20.3% YoY
Net profit and EPS: ₹158.71 crore, down 13.0% YoY; basic EPS ₹52.89
Profit to owners: ₹155.72 crore for the quarter; ₹401.02 crore for six months, up 30.6%
Finance costs: ₹3.99 crore, down 18.4% YoY
Standalone
The company on its own, without its subsidiaries
Total income: ₹1,673.38 crore, up 14.0% YoY
Net profit and EPS: ₹141.44 crore, down 17.9% YoY; basic EPS ₹48.04
Tax: ₹44.48 crore, 23.9% of profit before tax of ₹185.92 crore
Summary
Consolidated ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
1,925.44
1,600.35
+20.3%
1,881.26
+2.3%
Revenue from operations
1,877.04
1,551.85
+21.0%
1,847.95
+1.6%
Other income
48.40
48.50
-0.2%
33.31
+45.3%
158.71
182.37
-13.0%
253.93
-37.5%
Finance costs
3.99
4.89
-18.4%
4.02
-0.7%
Depreciation
78.14
81.00
-3.5%
78.09
+0.1%
Tax expense
55.67
48.91
+13.8%
92.90
-40.1%
Net profit margin
8.24%
11.40%
-3.15 pp
13.50%
-5.26 pp
Tax as share of profit before tax
26.0%
21.1%
+4.82 pp
26.8%
-0.82 pp
EPS, basic (₹)
52.89
60.88
-13.1%
83.32
-36.5%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Consolidated net profit fell 13.0% YoY to ₹158.71 crore while total income rose 20.3% to ₹1,925.44 crore. Revenue from operations rose 21.0% to ₹1,877.04 crore, and other income was ₹48.40 crore against ₹48.50 crore a year earlier.
Tax expense was ₹55.67 crore, 26.0% of profit before tax of ₹214.38 crore. A year earlier tax was ₹48.91 crore, 21.1% of profit before tax of ₹231.28 crore.
Profit attributable to owners of the company was ₹155.72 crore for the quarter against ₹179.24 crore a year earlier, and basic EPS was ₹52.89 against ₹60.88. For the six months, profit attributable to owners was ₹401.02 crore against ₹307.01 crore, up 30.6%.
Segment revenue from Performance and Other Chemicals was ₹1,503.94 crore for the quarter, against ₹1,145.11 crore a year earlier. Life Science Chemicals was ₹427.27 crore against ₹439.97 crore.
Standalone ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
1,673.38
1,468.05
+14.0%
1,614.91
+3.6%
Revenue from operations
1,623.46
1,409.52
+15.2%
1,588.60
+2.2%
Other income
49.92
58.53
-14.7%
26.31
+89.7%
141.44
172.31
-17.9%
201.03
-29.6%
Finance costs
0.74
1.20
-38.3%
0.73
+1.4%
Depreciation
52.01
54.75
-5.0%
52.07
-0.1%
Tax expense
44.48
49.53
-10.2%
68.82
-35.4%
Net profit margin
8.45%
11.74%
-3.28 pp
12.45%
-4.00 pp
Tax as share of profit before tax
23.9%
22.3%
+1.60 pp
25.5%
-1.58 pp
EPS, basic (₹)
48.04
58.53
-17.9%
68.28
-29.6%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone net profit fell 17.9% YoY to ₹141.44 crore while total income rose 14.0% to ₹1,673.38 crore. Revenue from operations rose 15.2% to ₹1,623.46 crore, and other income fell 14.7% to ₹49.92 crore.
Tax expense was ₹44.48 crore, 23.9% of profit before tax of ₹185.92 crore, against 22.3% a year earlier. Basic EPS was ₹48.04 against ₹58.53.
Consolidated net profit of ₹158.71 crore is ₹17.27 crore higher than standalone net profit of ₹141.44 crore. Finance costs were ₹0.74 crore, against ₹1.20 crore a year earlier.
Inference
The board approved a buy-back of fully paid-up equity shares of up to ₹90 crore, at up to ₹7,500 a share, excluding transaction costs. The indicative maximum is 1,20,000 shares, or 0.41% of outstanding equity shares. The public announcement with the process and timelines will be released later.
The board approved Price Waterhouse Chartered Accountants LLP as statutory auditors for five years, from the 50th AGM in 2027 to the 55th AGM in 2032, subject to shareholder approval. Deloitte Haskins & Sells LLP continues until the 50th AGM. Dividends on equity shares of ₹88.32 crore were paid in the six months, per the cash flow statement.
The auditors' review of the standalone results has no modification; for the consolidated results they relied on other auditors' reports for three subsidiaries and did not modify their conclusion. The filing does not give the reason for the fall in consolidated profit or the timing of the buy-back.
Create a free account to read the rest of this article and the analysis that follows.
By continuing you agree to our Terms and Privacy Policy, and to receive updates from Blacklitt by email. You can unsubscribe anytime.
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
